Technology

XBiotech

$18.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.53 (-2.85%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell XBiotech and other stocks, options, and ETFs commission-free!

About XBIT

XBiotech Inc. Common Stock, also called XBiotech, is a biopharmaceutical company. The firm engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX. The listed name for XBIT is XBiotech Inc. Common Stock.

CEO
John Simard
Employees
60
Headquarters
Austin, Texas
Founded
2005
Market Cap
497.90M
Price-Earnings Ratio
1.24
Dividend Yield
—
Average Volume
176.48K
High Today
$19.14
Low Today
$17.83
Open Price
$18.63
Volume
155.47K
52 Week High
$23.87
52 Week Low
$8.72

Collections

XBIT Earnings

-$0.63
-$0.42
-$0.21
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 15, Pre-Market

You May Also Like

DTE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure